Subscribe
19 September 2017Americas

Video interview: Allen & Overy on the UPC and CRISPR

The Unified Patent Court (UPC) is likely to spark years of uncertainty and may even become part of the UK’s negotiations for Brexit.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Video interview: Allen & Overy on CRISPR evolution
22 September 2017   To evaluate how the CRISPR licensing landscape might evolve, parties need to analyse the current patent environment.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Americas
Video interview: Allen & Overy on CRISPR evolution
22 September 2017   To evaluate how the CRISPR licensing landscape might evolve, parties need to analyse the current patent environment.

More on this story

Americas
Video interview: Allen & Overy on CRISPR evolution
22 September 2017   To evaluate how the CRISPR licensing landscape might evolve, parties need to analyse the current patent environment.

More features

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims